Amla

Amla (Phyllanthus emblica, syn. Emblica officinalis) is the fruit of a small-to-medium deciduous tree in the Phyllanthaceae family, native to tropical and subtropical South and Southeast Asia. The round, pale greenish-yellow fruits are intensely sour and astringent, with six faint vertical furrows, and have been prized across Indian medicine for thousands of years.

In Ayurveda, amla (known as amalaki) is one of the most revered rasayanas, or rejuvenative tonics. It is unusual in being tridoshic, balancing Vata, Pitta and Kapha, and is the central ingredient of two classic formulas: Triphala and Chyawanprash.

Amla's reputation as a vitamin C powerhouse deserves a nuance. While the fruit is genuinely one of the most antioxidant-dense foods known, much of what older assays measured as vitamin C is actually the activity of its hydrolyzable tannins (emblicanin A and B, punigluconin, pedunculagin) and polyphenols such as gallic acid, ellagic acid and quercetin. Popular claims of 20 to 30 times the vitamin C of an orange conflate true ascorbic acid with tannin activity and are best treated as marketing. The practical point stands, amla is a potent antioxidant, but it is not a vitamin C megadose.

Today amla is taken as dried fruit powder, juice, capsules and standardized extracts (such as Capros and Saberry), used mainly for cardiovascular and metabolic support, antioxidant and immune support, digestion, and hair and skin health.

In Ayurveda, amalaki is classified as tridoshic and is a flagship rasayana, a rejuvenative said to promote longevity, vitality, intellect (medhya) and resistance to disease. Its cooling action makes it a classic Pitta pacifier, and within Triphala it supplies the Pitta-balancing, rejuvenative component, alongside Haritaki for Vata and Bibhitaki for Kapha.

Traditional applications span digestion (appetite, acidity and constipation, largely via Triphala), hair (strengthening, darkening and reducing premature graying, in oils and rinses), skin and complexion, eyes and vision, and blood-building for anemia. Amla also features in Siddha, Unani and Tibetan medicine for similar tonic, digestive and cooling indications.

Across these traditions amla is valued as a nourishing rasayana taken over months rather than an acute remedy. These uses rest on classical texts and long ethnobotanical practice rather than modern controlled trials.

The strongest modern human evidence is cardiometabolic. A 2023 systematic review and meta-analysis of five randomized trials found amla supplementation significantly reduced LDL cholesterol, total cholesterol, triglycerides, fasting glucose and CRP while raising HDL. The best-characterized product, a standardized extract (Capros), produced dose-dependent lipid, inflammatory and endothelial improvements over 12 weeks.

Antioxidant activity is the most consistently demonstrated property and the likely mechanistic thread behind the rest, supported by both preclinical data and human biomarker changes. Glycemic effects are promising, one open-label trial found a standardized extract non-inferior to metformin over three months, but rest on relatively few trials. A small randomized trial suggests benefit for non-erosive reflux (heartburn) symptoms.

Most other reputed uses, including hair, skin, liver protection, anticancer, neuroprotection, immune and longevity effects, remain preclinical or traditional-only. Overall: moderate evidence for lipids and antioxidant status, moderate-to-preliminary for blood glucose, preliminary for reflux, and traditional or preclinical for everything else. Human trials are mostly small and short, typically around 12 weeks.